Wed, February 16, 2022
Tue, February 15, 2022
Mon, February 14, 2022
Fri, February 11, 2022
Thu, February 10, 2022
Wed, February 9, 2022
Tue, February 8, 2022
Mon, February 7, 2022
Fri, February 4, 2022

Andrew Mok Upgraded (THC) to Strong Buy and Increased Target to $111 on, Feb 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. nd-increased-target-to-111-on-feb-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Mok of UBS, Upgraded "Tenet Healthcare Corporation" (THC) to Strong Buy and Increased Target from $83 to $111 on, Feb 10th, 2022.

Andrew has made no other calls on THC in the last 4 months.



There are 10 other peers that have a rating on THC. Out of the 10 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $92 on, Tuesday, November 9th, 2021


These are the ratings of the 9 analyists that currently disagree with Andrew


  • A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $111 on, Wednesday, February 9th, 2022
  • David Macdonald of "Truist Securities" Upgraded from Hold to Strong Buy and Held Target at $90 on, Wednesday, February 9th, 2022
  • Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $100 on, Wednesday, February 9th, 2022
  • Sarah James of "Barclays" Maintained at Buy with Increased Target to $99 on, Wednesday, February 9th, 2022
  • Whit Mayo of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $100 on, Wednesday, February 9th, 2022
  • John Ransom of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $120 on, Thursday, January 20th, 2022
  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $90 on, Wednesday, November 10th, 2021
  • Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Monday, October 25th, 2021
  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Friday, October 22nd, 2021

Publication Contributing Sources